Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • FEDERAL PREEMPTION—W.D. La;.E.D. Mo.: Kalshi sues Louisiana, Missouri over sports-wagering laws
    • CFTC NEWS AND SPEECHES—CFTC ‘Frontier Forum’ weighs rules, liability for agentic trading
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • COMMODITY FUTURES—CFTC judge dismisses investor's claim against third-party FCM
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • FRAUD AND MANIPULATION—D.N.J.: Drug company misled about trial delays, but can plaintiffs prove scienter?
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • FRAUD AND MANIPULATION—N.D. Cal.: Court grants final approval of $47.75 million settlement in Hawaii wildfire class action
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • OVERSIGHT AND INVESTIGATION—Warren seeks Anthropic answers on prospective IPO’s AI, financial risks
      • You have 1 more complimentary views available this month. Log in if you are already a customer
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Securities Regulation Daily Wrap Up, FRAUD AND MANIPULATION—D.N.J.: Drug company misled about trial delays, but can plaintiffs prove scienter?, (Oct 29, 2026)

    Law Firms Mentioned:K&L Gates LLP | Levi & Korsinsky LLP
    Organizations Mentioned:Rocket Pharmaceuticals, Inc.

    By Anne Sherry, J.D.

    The plaintiffs have 30 days to improve their scienter allegations.

    A securities-fraud complaint pleaded several misrepresentations about the reasons for a drug trial’s delays but failed to adequately allege scienter. After culling major section ...

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use